LOGO
LOGO

Intraday Alerts

OptimizeRx Stock Jumps 37% After Reporting Q4 Results, Outlook

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024

Shares of OptimizeRx Corporation (OPRX) jumped over 37% on Wednesday morning after reporting results for the fourth quarter and issued an outlook for the full year 2025.

OPRX is currently trading at $5.69, up $1.55 or 37.53%, on the Nasdaq. The stock opened its trading at $4.85 after closing Tuesday at $4.14. The stock has traded between $3.78 and $14.13 in the past 52-week period.

Fourth-quarter revenues increased 14% to $32.3 million, from $28.4 million in the same period of 2023.

Net loss in the fourth quarter totaled $0.1 million or $0.00 per share compared to net loss of $4.1 million or $0.23 per share last year.

Adjusted net income in the fourth quarter was $5.5 million or $0.30 per share compared to $4.6 million or $0.26 per share last year.

Looking forward to the full year 2025, the company expects revenues to be at least $100 million with an adjusted EBITDA of at least $12 million.

For comments and feedback contact: editorial@rttnews.com

Business News

Get Access to Premium Stock Alerts with RTT Biotech Investor.
Global Economics Weekly Update -June 15 - June 19, 2026

June 19, 2026 16:46 ET
Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.